RDC 166/2017
Validation of analytical methods
Current edition
RDC 166 of July 24, 2017 (in force)
Current edition
RDC 166 of July 24, 2017 (in force)
About this standard
Criteria for validating analytical methods used on pharmaceutical ingredients, medicines and biological products in all production phases.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Brazil
- Validation of analytical methods: parameters, compendial methods, method transfer and reference substancesAnalytical method validation · Not stated
- Nitrosamines: risk assessment, confirmatory tests and control in active ingredients and medicinesImpurities · Not stated
- Quality dossier for synthetic medicines: specifications, analytical reports, batch records and process validationSpecifications · Local test (some cases)
Related standards: FDA analytical procedures guidance, Q2(R2), USP <1224>, USP <1225>, USP <1226>, USP <621>, Q14, M10, ASEAN analytical validation guideline, Taiwan analytical validation manual. See all standards.